老年人可溶性CD14及炎症标志物与糖代谢异常
在基于人群的老年队列中评估sCD14、IL-6、CRP和白细胞计数与胰岛素抵抗及2型糖尿病发病的关联,并用孟德尔随机化分析评估sCD14的因果作用。中位随访11.6年间发生466例糖尿病;sCD14与胰岛素抵抗横断面相关,但互调后消失且无因果证据,白细胞计数与糖尿病风险关联最稳健。
要点
- sCD14与胰岛素抵抗相关,但校正其他炎症标志物后关联消失
- 孟德尔随机化未支持sCD14对胰岛素抵抗的因果作用
- 白细胞计数是該老年人群中与糖尿病风险关联最稳健的炎症指标
核心结论
- 在老年人群中,sCD14与胰岛素抵抗相关但校正其他生物标志物后消失、无因果证据,且与糖尿病无类似关联;IL-6、CRP和白细胞计数均与胰岛素抵抗和糖尿病相关,其中白细胞计数关联最稳健。
研究设计与样本
- 基于人群的老年队列研究(心血管健康研究),分析sCD14、IL-6、CRP和白细胞计数与胰岛素抵抗及2型糖尿病发病的关联。
- 采用工具变量法的孟德尔随机化评估sCD14对胰岛素抵抗的因果作用。
主要发现
- 校正传统危险因素后,四种生物标志物均与两项胰岛素抵抗指标呈正横断面关联。
- 相互校正所有标志物后,除sCD14外其他标志物的关联持续存在。
- 中位随访11.6年间发生466例糖尿病,除sCD14外所有标志物与糖尿病正相关。
- 相互校正后仅白细胞计数仍与糖尿病相关(每倍增风险比1.43,95%CI 1.07–1.90)。
- 工具变量分析未支持sCD14对胰岛素抵抗的因果作用。
关键数值与推荐
- 白细胞计数每倍增与糖尿病风险比1.43(95%CI 1.07–1.90),为相互校正后唯一仍显著者。
- 中位随访11.6年,糖尿病事件466例。
临床怎么用
- 在老年人群中评估糖尿病炎症风险时,白细胞计数较sCD14更具参考价值。
- sCD14不宜作为独立的胰岛素抵抗或糖尿病风险标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Experimental studies have implicated soluble (s)CD14, an effector of lipopolysaccharide-induced inflammation, in insulin resistance, but its role in human metabolic endotoxemia has not been studied. We evaluated sCD14 in relation to dysglycemia in older adults and how this compares to other markers of inflammation. RESEARCH DESIGN AND METHODS: We investigated associations of sCD14, interleukin-6 (IL-6), CRP, and white blood cell (WBC) count with insulin resistance (quantitative insulin-sensitivity check index and HOMA 2 of insulin resistance) and incident type 2 diabetes in a population-based cohort of older adults. We also assessed the causal role of sCD14 in insulin resistance using an instrumental variable approach by Mendelian randomization. RESULTS: After adjustment for conventional risk factors, each of the four biomarkers showed positive cross-sectional associations with both insulin resistance measures. These associations persisted after mutual adjustment for all markers except sCD14. Over a median follow-up of 11.6 years, 466 cases of diabetes occurred. All biomarkers except sCD14 were positively associated with diabetes, although only WBC count remained associated (hazard ratio 1.43 per doubling [95% CI 1.07, 1.90]) after mutual adjustment. Instrumental variable analysis did not support a causal role for sCD14 in insulin resistance. CONCLUSIONS: Among older adults, sCD14 was associated with insulin resistance, but this disappeared after adjustment for other biomarkers, showed no evidence of a causal basis, and was not accompanied by a similar association with diabetes. IL-6, CRP, and WBC count were each associated with insulin resistance and diabetes, WBC count most robustly. These findings do not support a central role for sCD14, but they highlight the preeminence of WBC count as an inflammatory measure of diabetes risk in this population.
引用
- Shitole SG, Biggs ML, Reiner AP, et al. Soluble CD14 and CD14 Variants, Other Inflammatory Markers, and Glucose Dysregulation in Older Adults: The Cardiovascular Health Study. Diabetes Care. 2019. PMID: 31471378. doi:10.2337/dc19-0723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。